Summary:
Click image to enlargeResearchers at Clinical Research Institute are conducting a Phase 3 clinical research study to evaluate the effectiveness of a potential medication for the prevention of migraines for those with prior unsuccessful preventive treatments.
Qualified Participants Must:
• Be aged 18-75 years old
•
Have been diagnosed with migraines for at least 12 months
•
Have migraine symptoms on at least 4 days per month
•
Have a history of prior unsuccessful preventive treatments
Qualified Participants May Receive:
All qualified participants will receive compensation for time and travel expenses.